SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-170425
Filing Date
2020-06-16
Accepted
2020-06-16 16:30:57
Documents
5
Period of Report
2020-06-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d944845d8k.htm 8-K 21185
2 EX-3.1 d944845dex31.htm EX-3.1 26583
3 EX-3.2 d944845dex32.htm EX-3.2 151781
4 EX-99.1 d944845dex991.htm EX-99.1 6734
5 GRAPHIC g944845g64z25.jpg GRAPHIC 3888
  Complete submission text file 0001193125-20-170425.txt   213024
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 20966810
SIC: 2836 Biological Products, (No Diagnostic Substances)